STANDARD EXCLUSIVE LICENSE AGREEMENT WITH SUBLICENSING TERMSStandard Exclusive License Agreement • November 18th, 2016 • Spotlight Innovation, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 18th, 2016 Company Industry
EXCLUSIVE LICENSE AGREEMENT OF OCTOBER 13, 2016 between INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION and SPOTLIGHT INNOVATION, INC.Exclusive License Agreement • November 18th, 2016 • Spotlight Innovation, Inc. • Pharmaceutical preparations • Indiana
Contract Type FiledNovember 18th, 2016 Company Industry JurisdictionIntroduction: This exclusive license agreement (the “Agreement”) is made and entered into as of October 13, 2016 (the “Effective Date”) by and between:
LICENSE AGREEMENTLicense Agreement • November 18th, 2016 • Spotlight Innovation, Inc. • Pharmaceutical preparations • Iowa
Contract Type FiledNovember 18th, 2016 Company Industry JurisdictionThis License Agreement (hereinafter called “Agreement”), to be effective as of the 29th day of August, 2016 (hereinafter called "Agreement Date"), is by and between Paul Reid, an individual having an address of 9610 NW 24 Court, Sunrise, FL 33322 (hereinafter called “Reid”), and Caretta Therapeutics, Inc. a corporation organized under the laws of Iowa, and having a principal place of business at 6750 Western Parkway, Suite 200 226, West Des Moines, Iowa 50266 and its Affiliates (hereinafter, collectively referred to as “Caretta Therapeutics”) (together, the “Parties” and individually, a “Party”).